Article Sidebar

PDF
Date Published: 25/06/2024
Online Published: 16/05/2024
Abstract Views: 68
Views PDF: 28
DOI: https://doi.org/10.58490/ctump.2024i7.2974
Issue
No. 7 (2024): SỐ TIẾNG ANH
Section
Article
How to Cite
Ly, Q. Y., Dang, B. L., Duong, M. T., Pham, T. T., & Le, V. M. (2024). STUDY OF CLINICAL CHARACTERISTICS AND SOME RISK FACTORS OF MIGRAINE HEADACHE AT CAN THO CENTRAL GENERAL HOSPITAL IN 2022-2023. Cantho Journal of Medicine and Pharmacy, 7, 158-163. https://doi.org/10.58490/ctump.2024i7.2974

STUDY OF CLINICAL CHARACTERISTICS AND SOME RISK FACTORS OF MIGRAINE HEADACHE AT CAN THO CENTRAL GENERAL HOSPITAL IN 2022-2023

Quoc Y Ly1, Bich Loan Dang1, Minh Thai Duong1, To Tran Pham1, Van Minh Le1,
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Migraine is a common disorder; however, it is still not perfectly diagnosed and treated due to many difficulties in recognizing symptoms or accompanying risk factors. Understanding migraine headaches through surveying standard samples can guide clinicians in the appropriate way of diagnosis and treatment. Objectives: The study aimed to describe the clinical characteristics of migraine and to investigate some risk factors related to migraine headaches among patients examined at Can Tho Central General Hospital during 2022-2023. Materials and methods: A cross-sectional descriptive study was conducted on 46 patients diagnosed with migraine headaches at Can Tho Central General Hospital in 2022-2023. Results: We recorded that most of the patients experienced headaches lasting from 24 to 72 hours, unilateral (left or right side) fixed headaches, pulsatile headaches and severe intensity headaches with the proportions being 39.14%, 73.9%, 80.4%, and 63.1% respectively.  The symptoms accompanying the headache included nausea (67.4%), photophobia (52.2%), dizziness (34.8%), vomiting (32.6%), and absence of aura symptoms (unilateral fixed headache, nausea or/and vomiting, photophobia or/and phonophobia) accounting for 95.7%. Factors exacerbating headaches are stimulant use (21,7%), weather (19,6%), menstrual conditions aggravating headaches in 16.7% of female patients, and physical activity (13.0%). Factors alleviating headaches include using analgesics (60,9%), resting (39.1%), and avoiding exposure to light and photophobia (4.3%). Influencing factors include female (65.2%), insomnia (58.7%), anxiety disorder (52.2%), and family history of having a parent with migraine disease (4.3%). Conclusion: The highest rates were observed among patients experiencing unilateral (left or right side) fixed pain (73.9%) and pulsatile headache (80.4%). The most common accompanying symptom is nausea (67.4%). The proportion of migraineurs without aura symptoms accounts for 95.7%. Stimulant use (21.7%) is the factors that exacerbate headaches the most. On the other hand, avoiding exposure to light and noise reduces headaches in most cases (accounting for 60.9%).  

Article Details

Keywords

Migraine headaches, migraineurs, clinical characteristics, risk factors

References

1. Kasper DL et al (2018), Chapter 422: migraine and other primary headache disorders, Harrison's Principles of Internal Medicine 20/E (Vol1 & Vol2). New York, NY: McGraw-Hill Education.
2. GBD 2016 Headache Collaborators (2018). Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology, 17(11), 954–976, https://doi.org/10.1016/S14744422(18)30322-3.
3. Ly Thanh Hung (2017), Classification of primary headaches at the neurological clinic of Nguyen Trai hospital, Level II specialist thesis, Ho Chi Minh City University of Medicine and Pharmacy.
4. Burch R. (2021). Preventive Migraine Treatment. Continuum (Minneapolis, Minn.), 27(3), 613– 632, https://doi.org/10.1212/CON.0000000000000957.
5. Lam Tuyen Uyen (2020), Research on some risk factors and evaluate the results of treatment to prevent recurrence of migraine headaches with Sodium Valproate, Can Tho Journal of Medicine and Pharmacy, (30), pp. 102-107.
6. Phuong, Do Thi Kim, Nguyen Trung Kien, and Nguyen Thi Nhu Truc. "Clinical characteristics and the efficacy of Topiramate in Migraine prevention." Tạp chí Y Dược học Cần Thơ 47 (2022): 1-6.
7. Chuan Hu, Yixin Zhang and Ge Tan (2021), “Advances in topiramate as prophylactic treatment for migraine”, Brain and Behavior, 11 (10), pp. 2290, https://doi.org/10.1002/brb3.2290.
8. David W Dodick (2009), Fred Freitag, James Banks, Joel Saper, Jim Xiang and et al. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clinical therapeutics, 31(3), 542–559, https://doi.org/10.1016/j.clinthera.2009.03.020.
9. Nguyen Ngoc Anh Thu (2017), Research on clinical characteristics, risk factors, assessment of treatment results for migraineurs at Can Tho University of Medicine and Pharmacy Hospital, Master's thesis in medicine, Can Tho University of Medicine and Pharmacy.
10. Andreas Straube, Anna Andreou (2019). Primary headaches during lifespan. The journal of headache and pain, 20(1), 35, https://doi.org/10.1186/s10194-019-0985-0.
11. Nguyen Anh Diem Thuy (2011), Clinical characteristics and quality of life in patients with chronic daily headaches, Master's thesis in medicine, Ho Chi Minh City University of Medicine and Pharmacy.
12. Nguyen Van Chuong (2013), "Headache with human history", Diagnosis and treatment of common headache diseases, Medical Publishing House, Hanoi, pp. 93-185.
13. Vu Quang Bich (2008), "Migraines", Prevention and treatment of all types of headaches, Medical Publishing House, Hanoi, pp. 210-281.
14. Nguyen Van Chuong (2013), "Headache with human history", Diagnosis and treatment of common headache diseases, Medical Publishing House, Hanoi, pp. 9-14.